Moleculin Announces ANNAMYCIN presentations at AACR & pancreatic conferences
Moleculin announced data presentations on Annamycin at three cancer conferences, focusing on its mechanism, organ distribution, and interaction with the immune system in pancreatic tumors.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day